No pain, no gain: Ozempic’s quest for market share



This content originally appeared on Reuters and was authored by Reuters


This content originally appeared on Reuters and was authored by Reuters


Print Share Comment Cite Upload Translate Updates
APA

Reuters | Sciencx (2025-09-11T04:16:58+00:00) No pain, no gain: Ozempic’s quest for market share. Retrieved from https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/

MLA
" » No pain, no gain: Ozempic’s quest for market share." Reuters | Sciencx - Thursday September 11, 2025, https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/
HARVARD
Reuters | Sciencx Thursday September 11, 2025 » No pain, no gain: Ozempic’s quest for market share., viewed ,<https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/>
VANCOUVER
Reuters | Sciencx - » No pain, no gain: Ozempic’s quest for market share. [Internet]. [Accessed ]. Available from: https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/
CHICAGO
" » No pain, no gain: Ozempic’s quest for market share." Reuters | Sciencx - Accessed . https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/
IEEE
" » No pain, no gain: Ozempic’s quest for market share." Reuters | Sciencx [Online]. Available: https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/. [Accessed: ]
rf:citation
» No pain, no gain: Ozempic’s quest for market share | Reuters | Sciencx | https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/ |

Please log in to upload a file.




There are no updates yet.
Click the Upload button above to add an update.

You must be logged in to translate posts. Please log in or register.